Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.34 |
| ▸ | EGFR | P00533 | 1/20 | 0.34 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21543066 | 0.88 | SRC (0.37) | TYRCYP1A2CYP3A4CYP2B6EGFR | |
| SCHEMBL28217671 | 0.84 | TYR (0.32) | TYRCYP1A2CYP3A4CYP2B6EGFR | |
| SCHEMBL28217668 | 0.84 | TYR (0.32) | TYRCYP1A2CYP3A4CYP2B6EGFR | |
| SCHEMBL2597919 | 0.77 | CA1 (0.56) | CYP1A2CYP3A4CYP2B6EGFRCA1 | |
| Ethane SCHEMBL2153523 | 0.76 | TYR (0.45) | TYRCYP1A2CYP3A4CYP2B6EGFR | |
| SCHEMBL17127345 | 0.74 | TYR (0.39) | TYRCYP1A2CYP3A4CYP2B6ALDH1A3 | |
| SCHEMBL2098283 | 0.74 | TYR (0.39) | TYRCYP1A2CYP3A4CYP2B6ALDH1A3 | |
| SCHEMBL5370178 | 0.74 | ALDH1A1 (0.39) | TYRALDH1A3ALDH1A1CYP2A6 | |
| SCHEMBL9231758 | 0.73 | TYR (0.52) | TYRALDH1A3ALDH1A1CYP2A6 | |
| SCHEMBL461449 | 0.72 | CA1 (0.55) | CYP1A2CYP3A4ALDH1A1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6969711-B2 | Cyclic diamine compounds and medicine containing the same | KOWA COMPANY, LTD. (JP) | 2005-11-29 | — | — | US | disclosed |
| US-20040038987-A1 | Novel cyclic diamine compounds and medicine containing the same | KOWA COMPANY, LTD. (JP) | 2004-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040038987-A1 | Novel cyclic diamine compounds and medicine containing the same | LCAT, ACAT2, ACAT1 | TYR 2628/4885CYP1A2 872/4885CYP3A4 1883/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.